Hadasit: Taking Hadassah Hospital’s Research To The Next Level

— by Ronit Treatman

Did you know that your body can reject a bone marrow transplant?  

It happens to one out of every three transplant recipients.  This condition is called Graft-versus-host disease.  When this occurs, your transplant attacks you.  Currently, this leads to death.  Researchers at Hadassah Hospital are now conducting human clinical trials on a therapy that can help the body accept and coexist with its bone marrow transplant.  This research is being conducted by one of Hadasit Bio-Holding‘s companies called Enlivex Therapeutics.  

By bringing this therapy to the world, Hadassah is furthering its mission of commitment to “Excellence in research by which the frontiers of medicine are advanced and mankind benefits.”